Canon BioMedical Genotyping Assays

Canon BioMedical, a wholly owned subsidiary of Canon USA, has launched a line of genotyping assays to detect SNPs, small insertions, and deletions in the human genome. Called Novalelle, the research-use-only assays are designed for rapid PCR followed by high-resolution melt analysis. At launch the firm will market 103 pre-designed assays as well as an "open" chemistry for researchers to customize, as reported by GenomeWeb.